Pharmacy

Renitec Vasotec

Home » Prescription Drugs 14 » Renitec Vasotec

Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Renitec is indicated in the treatment of hypertension (includes combination with hydrochlorothiazide). Renitec is indicated for the treatment of symptomatic congestive heart failure usually in combination with diuretics and digitalis. Asymptomatic left ventricular dysfunction. Enalapril is in a group of drugs called ACE inhibitors. ACE stands for angiotensin converting enzyme. Enalapril is used to treat high blood pressure (hypertension) congestive heart failure kidney problems caused by diabetes and to improve survival after a heart attack.

Buy Renitec Vasotec and other Prescription Drugs 14 products online at Medstore.

Buy Online at Medstore - Click Here!

About Renitec Vasotec:

Product Type: Prescription Drugs 14

Renitec ( Vasotec Generic Enalapril )

Renitec (Vasotec Generic Enalapril)

Vasotec Generic Enalapril

10mg Vasotec Generic Enalapril Renitec

View more Prescription Drugs 14

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.